News Around the World: BiVACOR Total Artificial Heart Makes History
The Texas Heart Institute, located in the heart of the Texas Medical Center, broadcasted a live press conference from The...
All
The Texas Heart Institute Provides BiVACOR® Total Artificial Heart Patient Update
Successful first-in-human bridge to heart transplant with revolutionary valveless artificial heart Houston, Texas, July 26, 2024 – The Texas Heart...
The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant ...
The Texas Heart Institute to Host Inaugural Cardiometabolic Syndrome Conference: Addressing a Global Health Crisis
Houston, TX (July 10, 2024) – The Texas Heart Institute is proud to announce the inaugural Cardiometabolic Syndrome Conference taking...
The Texas Heart Institute Journal: Volume 51, Issue 1
The Texas Heart Institute Journal Volume 51, Issue 1 January–June 2024 ORIGINAL RESEARCH Clinical Investigation Comparison of Perioperative...
Welcome Our Incoming Cardiovascular Disease Fellows
Each year, hundreds of young physicians apply to train in The Texas Heart Institute’s prestigious cardiology fellowship programs at Baylor...
THI Perfusion School Honors Asia Nguyen With Sal Guercio Memorial Scholarship
The Texas Heart Institute School of Perfusion Technology has honored student Asia Nguyen with the third annual Sal Guercio Memorial...
The Texas Heart Institute Honors the Perfusion School Class of June 2024
On June 14, The Texas Heart Institute’s School of Perfusion Technology congratulated the eight June 2024 graduates of its long-standing...
The Texas Heart Institute Fellowship Program Congratulates 2024 Cardiology Graduates
On June 7, The Texas Heart Institute honored 11 graduates of its Cardiovascular Disease Fellowship and subspecialty cardiology fellowship programs....
A Discovery by The Texas Heart Institute & 7 Hills Pharma Continues Development under a $4.7 Million CPRIT Grant to Address Cancer Treatment Disparities
Peter Vanderslice, PhD, Senior Investigator and Director, MCRL, Molecular Cardiology Research, was highlighted in a recent announcement from 7 Hills Pharma,...
Dr. Matthew Segar Recognized With DEI Abstract Award From Heart Rhythm Society
Novel Machine Learning Model Improves Prediction of Atrial Fibrillation Risk The Heart Rhythm Society recently recognized Matthew Segar, MD,...
Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia
Dr. Christie Mitchell Ballantyne, editorial board member for The Texas Heart Institute Journal, and professor of medicine and chief of...
